Cytiva Denmark ApS: Financial statements 2023
CVR: 43126261
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Cytiva Denmark ApS (CVR 43126261) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 101,050,505 and a net result of DKK 66,254,250. Equity in the 2023 report amounted to DKK 188,722,612. The solvency ratio was 34.7%. The company had 23 employees in the financial year.
- Gross Profit
- DKK 101,050,505
- Profit/Loss
- DKK 66,254,250
- Equity
- DKK 188,722,612
- Total Assets
- DKK 543,770,247
- Employees
- 23
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Cytiva Denmark ApS has published its interim report for the period March 15, 2022 to December 31, 2022.
As of March 9, 2023, Nils Tomas Ljunggren is registered as director of Cytiva Denmark ApS.
As of March 9, 2023, Marinus Adrianus Johannes Hazenberg is registered as director of Cytiva Denmark ApS.
About Cytiva Denmark ApS
Cytiva Denmark ApS is a Danish company of the type Anpartsselskab based in Brønshøj, founded in 2022. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Nicolaj Peter Saxild, Nils Tomas Ljunggren and Per Jonas Jakstad. The company is owned by Pall Norden AB. The company has 26 employees (2026). In 2025, the company reported revenue of DKK 1,718,386,073 and a net result of DKK 67,011,190 compared with DKK 80,542,305 the year before. Equity in the 2025 report amounted to DKK 146,276,107.